![](/images/Email.png)
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
AstraZeneca R&D Charnwood
Curated by ChEMBL
AstraZeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:In vitro inhibition of human Inducible nitric oxide synthase.More data for this Ligand-Target Pair
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
AstraZeneca R&D Charnwood
Curated by ChEMBL
AstraZeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of human recombinant iNOS by microtiter plate assayMore data for this Ligand-Target Pair
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
AstraZeneca R&D Charnwood
Curated by ChEMBL
AstraZeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of human inducible nitric oxide synthaseMore data for this Ligand-Target Pair
TargetNitric oxide synthase, inducible(Homo sapiens (Human))
AstraZeneca R&D Charnwood
Curated by ChEMBL
AstraZeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 1.41E+3nMAssay Description:Inhibition of human iNOS assessed as inhibition of [3H]L-arginine to [3H]L-citrulline conversion by scintillation countingMore data for this Ligand-Target Pair
![](/img/powered_by_small.gif)